about
The Safety of a Conservative Fluid Replacement Strategy in Adults Hospitalised with MalariaHIV care in Yangon, Myanmar; successes, challenges and implications for policy.The clinical implications of thrombocytopenia in adults with severe falciparum malaria: a retrospective analysis.A simple score to predict the outcome of severe malaria in adults.The epidemiology and clinical features of melioidosis in Far North Queensland: Implications for patient managementHigh Frequency of Clinically Significant Bacteremia in Adults Hospitalized With Falciparum Malaria.Prognostic indicators in adults hospitalized with falciparum malaria in Western Thailand.Rapid clinical assessment to facilitate the triage of adults with falciparum malaria, a retrospective analysis.The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study.Case Report: Endemic Amebiasis in Australia: Implications for Residents, Travelers, and Clinicians.Melioidosis mimicking primary lung malignancy with superior vena cava obstructionNontyphoidal Salmonella Bacteremia Resulting in Thoracic Aortic Dissection.Rabies in Myanmar: Prevalent, Preventable but not Prioritized.Constrictive, Calcific Pericarditis in a Scleroderma Patient.Prostatic Abscess due to Burkholderia pseudomallei: Facilitating Diagnosis to Optimize Management.Extensive Dystrophic Calcinosis Cutis: A Severe Complication of Polymyositis/Systemic Sclerosis Overlap Syndrome.Case Report: Fatal Pediatric Melioidosis Despite Optimal Intensive Care.Melioidosis in Far North Queensland is not correlated with severe weather events.The clinical characteristics of adults with rheumatic heart disease in Yangon, Myanmar: An observational study.Antibiotic Therapy in Adults with Malaria: High Rate of Clinically Significant Bacteremia in Hospitalized Adults Diagnosed with Falciparum MalariaMelioidosis: An Australian PerspectiveThe clinical characteristics of patients with sepsis in a tertiary referral hospital in Yangon, MyanmarSuccessful outpatient management of bacteremia in an immunocompetent patient with endovascular involvementHemophagocytic Lymphohistiocytosis Complicating MelioidosisA decentralised, multidisciplinary model of care facilitates treatment of hepatitis C in regional AustraliaA simple score to predict severe leptospirosisMELAS syndrome in an Indigenous Australian womanThe microbiology of crocodile attacks in Far North Queensland: implications for empirical antimicrobial therapyHTLV-1 is rare in Far North Queensland despite a significant burden of classically associated diseasesAntibiotic Prophylaxis for Melioidosis in Patients Receiving Hemodialysis in the Tropics? One Size Does Not Fit AllThe microbiology of ear cultures in a high-burden setting in tropical Australia: Implications for cliniciansChromobacterium violaceum in Northern Australia: A Sheep in Wolf's Clothing?Melioidosis in the Torres Strait Islands, Australia: Exquisite Interplay between Pathogen, Host, and EnvironmentSequential Helicobacter pylori eradication therapy in Myanmar; a randomized clinical trial of efficacy and tolerabilitySevere leptospirosis in tropical Australia: Optimising intensive care unit management to reduce mortalityThe epidemiology and clinical features of rickettsial diseases in North Queensland, Australia: Implications for patient identification and managementClinical Utility of Platelet Count as a Prognostic Marker for MelioidosisImproving the mortality of severe leptospirosis
P50
Q28551039-5A5BEEFF-54E9-4EB7-A006-B85133DC461BQ30378383-62A8F75B-DC14-4393-BA84-3F7367F402CAQ33422287-8D928A29-7DC2-4B33-BC66-745E6DE5706CQ35036422-225A7990-4243-4A71-BA2D-A90D751A96B9Q36298405-9354F560-E904-4DDD-BB28-4F01106F6D40Q36694858-47BD5A1E-1049-42A1-AF26-5F1203FAE31DQ37014184-A778913D-7634-463D-96BD-947D5F8FD77DQ37529508-C2E016A6-5A22-4D89-A331-87ABCECDCC34Q40095857-93800C22-974B-4B02-B456-2F38CBC5BD2AQ40118434-620FE7C3-769E-4A15-8439-C369EF4EC596Q41348366-A8ADFA44-84E3-495E-93B9-ECFDD65F75A3Q41662433-28CCAB39-CD0F-4635-A861-B9AAB1CEDAA2Q47308196-478A8D11-A63A-4AD1-88E7-4E8335976612Q49928865-757AAC29-C136-42F1-902A-D31FC5ED71B0Q49989805-9AE71D5B-ABF7-4EBB-B200-25693FDAA804Q50020771-FD9801A4-880E-4D4B-9295-40D7D7CDD64AQ50088444-B7108F30-D261-491D-B2FD-1C142D77D137Q50242344-A2943733-8F90-4BEB-B47E-1CF02F80E73AQ52692062-6C654F59-0569-400C-84D2-D41BD5FEEF15Q56362512-AF97734B-C1BC-4583-ABE8-209EEFABB10CQ57147824-2B4882AE-AD56-484B-A66B-E0BC84142BE5Q58572273-7853994C-C61E-47F9-8553-52D912017369Q58600753-02989733-BDB3-48E1-B976-ACEFDD9049B0Q58772984-06FD61D5-6C67-44FC-AB6F-E8F14037FAD0Q59355919-93503602-C8E3-4FBF-8D86-7E742E340D78Q64130266-67B9570A-3B9E-49BB-9BB1-43A9E12EEC62Q82627646-A4558BFB-0CD1-45FE-9FFE-A1ADD94B98FAQ87820462-F4F2502A-080A-46C0-89D5-C68DD37519FEQ90021403-E60D1176-4275-446A-B3BC-554765CF2BD9Q90269273-3890DD77-F1A2-4606-BDB2-B63F531FEE10Q90415119-0770CCBA-3260-406D-96CC-7BFC169E4482Q90935818-2277D05E-6B1E-4233-A0C8-644CC0977880Q91191335-B3D458F5-D912-41BE-B544-05517CDF9FC1Q91407632-D16FD71D-113F-48DE-8627-35530274639AQ91603971-630BEB8E-80C0-43EC-9BF3-98506FF2AF03Q91989476-89000F2E-E603-4DE0-A4E7-E8D732CF55E3Q92471405-60CE705F-9CD7-44CA-BA1C-106C1B16036AQ92785430-13F6BF48-3CC5-496B-B8D8-340741C663B8
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Josh Hanson
@ast
Josh Hanson
@en
Josh Hanson
@es
Josh Hanson
@nl
type
label
Josh Hanson
@ast
Josh Hanson
@en
Josh Hanson
@es
Josh Hanson
@nl
prefLabel
Josh Hanson
@ast
Josh Hanson
@en
Josh Hanson
@es
Josh Hanson
@nl
P106
P1153
22034325200
P21
P31
P496
0000-0002-1423-3839